Aura Biosciences, Inc. · Brief

Next report

9 days

Nov 12 · before openest.Q3 FY26

Expected move

No implied move.

8 reportsHistory

0 of 7≥ implied

Mar 24 '25±15.1%▲+1.14%×0.08

May 15 '25—▲+5.71%—

Aug 13 '25±58.5%▲+4.18%×0.07

Q3 FY25±71.4%▼−0.72%×0.01

Q1 FY26±64.1%▼−1.12%×0.02

May 4 '26±44.7%▲+6.59%×0.15

May 11 '26±49.3%▼−3.17%×0.06

Q2 FY26±83.3%▲+4.42%×0.05

quarterimplied−85%0+85%realized×

Q2 FY26±83.3%▲+4.42%×0.05

May '26±49.3%▼−3.17%×0.06

May '26±44.7%▲+6.59%×0.15

Q1 FY26±64.1%▼−1.12%×0.02

Q3 FY25±71.4%▼−0.72%×0.01

Aug '25±58.5%▲+4.18%×0.07

2 older reports

May '25—▲+5.71%—

Mar '25±15.1%▲+1.14%×0.08

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 12 report · est.

Bull2 of 3

148managers reporting a position in the latest quarterly filings13F · Jun 30 '26

+48.03%change in shares held by the ten largest reporting managers over the latest quarter13F · Jun 30 '26

Bear2 of 4

7 of 7recent reports where the move came in under the options implied rangeEarnings history

4tracked funds holding AURAN-PORT · Aug 31 '26

AI captions · Sep 28 '26once per report · top 2 per case

AURA report session

No linked exposure.

No changes.

privateThesis 0 · Decisions 0 · Observations 0

No thesis.